Index of artpub/2019/224127/

Zandberg, D.P
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma : Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
2019
https://ddd.uab.cat/record/224127